InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Van Plew Daniel P, Chief Executive Officer. Director active across 1 company, notably Regeneron Pharmaceuticals, INC.. In total, 9 disclosures have been logged. Activity tracked since 9 August 2021. The latest transaction was disclosed on 22 February 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
40,000 shares@ US$399.660.019% mcap36.9% of flowCommon StockSEC:0001708138-22-000018:0
●
697 shares@ US$664.340.0006% mcap3.4% of flowCommon StockSEC:0001883850-21-000029
●
697 shares@ US$664.340.0006% mcap1.1% of flowCommon StockSEC:0001883850-21-000029:0
4,344 shares0Common StockSEC:0001708138-21-000095:0
4,344 shares0Common StockSEC:0001708138-21-000095
25,000 shares@ US$270.430.0081% mcap48.9% of flowCommon StockSEC:0001708138-21-000085
25,000 shares@ US$270.430.0081% mcap15.4% of flowCommon StockSEC:0001708138-21-000085:0
25,000 shares@ US$270.430.0079% mcap47.7% of flowCommon StockSEC:0001708138-21-000049
25,000 shares@ US$270.430.0079% mcap15.0% of flowCommon StockSEC:0001708138-21-000049:0
9 of 9 declarations
About Van Plew Daniel P
Daniel P. Van Plew is Executive Vice President and General Manager at Regeneron Pharmaceuticals, Inc. He oversees the strategic direction of the company, focusing on innovation in the pharmaceutical sector. With a strong background in the industry, he contributes to developing advanced therapeutic solutions.
